Skip to main content

Table 6 Fertilisation, embryo development and outcome in the ANA + cycles without P + A and the ANA + cycles with P + A

From: A retrospective study on IVF/ICSI outcome in patients with anti-nuclear antibodies: the effects of prednisone plus low-dose aspirin adjuvant treatment

Variables

Without P + A

With P + A

P

OPU cycles (IVF + ICSI)

21(11 + 10)

21 (11 + 10)

-

ET cycles

16

21

-

Semen volume (ml, ICSI cycles)

3.54+/-0.81

3.09+/-0.87

ns

Sperm concentration (×106/ml, ICSI cycles)

14.64+/-11.21

16.34+/-10.65

ns

Sperm progressive motility (%, ICSI cycles)

12.87+/-10.97

15.34+/-11.56

ns

Semen volume (ml, IVF cycles)

3.44+/-0.93

3.64+/-0.83

ns

Sperm concentration (×106/ml, IVF cycles)

62.56+/-43.78

66.23+/-39.23

ns

Sperm progressive motility (%, IVF cycles)

46.89+/-15.45

43.89+/-17.68

ns

Retrieved oocytes

8.10 +/- 3.95

9.24 +/- 4.10

ns

MII oocytes

6.50 +/- 4.09

7.20 +/- 3.99

ns

Two pro-nuclei

4.86 +/- 2.89

7.05 +/- 3.17

0.004

Perfect embryos

3.24 +/- 2.41

4.76 +/- 2.93

0.037

Available embryos

3.62 +/- 2.22

5.76 +/- 3.25

0.008

Embryos

4.81 +/- 2.93

6.90 +/- 3.24

0.006

Transferred embryos/cycle

2.06 +/- 0.44

2.76 +/- 0.58

0.008

Pregnancy rate (%)

12.5 (2/16)

57.1% (12/21)

0.006

Implantation rate (%)

6.06 (2/33)

27.9 (16/58)

0.013

Early miscarriage rate (%)

100 (2/2)

25 (3/12)

-

  1. P < 0.05 was considered to be statistically significant.